Search Results - "Nozynski, J"

Refine Results
  1. 1

    BRCA1 Reflects Myocardial Adverse Remodeling in Idiopathic Dilated Cardiomyopathy by Nozynski, J.K, Konecka-Mrowka, D, Zakliczynski, M, Zembala-Nozynska, E, Lange, D, Zembala, M

    Published in Transplantation proceedings (01-06-2016)
    “…Abstract Background The role of BRCA1 in chronic ischemic episodes seems to be pivotal for adverse remodeling and development of ischemic cardiomyopathy,…”
    Get full text
    Journal Article
  2. 2

    Persisting Mild Lesions in Coronary Angiography Prognosticate Poor Long-Term Survival of Heart Transplant Recipients by Zakliczynski, M, Babinska, A, Flak, B, Nozynski, J, Zembala, M

    “…Purpose Despite coronary angiography (CAG) underestimates coronary allograft vasculopathy (CAV), it remains a frame for ISHLT CAV classification. We performed…”
    Get full text
    Journal Article
  3. 3

    Fractal Analysis of Heart Graft Acute Rejection Microscopic Images by Pijet, M, Nozynski, J, Konecka-Mrowka, D, Zakliczynski, M, Hrapkowicz, T, Zembala, M

    Published in Transplantation proceedings (01-10-2014)
    “…Abstract Background Endomyocardial biopsy to evaluate rejection in the transplanted heart is accepted at the “gold standard.” The complexity of microscopic…”
    Get full text
    Journal Article
  4. 4
  5. 5

    In the Era of the Universal Use of Statins Dyslipidemia's are Still Common in Heart Transplant Recipients: A Cross-Sectional Study by Zakliczynski, M, Boguslawska, J, Wojniak, E, Zakliczynska, H, Ciesla, D, Nozynski, J, Szygula-Jurkiewicz, B, Zeglen, S, Zembala, M

    Published in Transplantation proceedings (01-10-2011)
    “…Abstract Background Statins are used in orthotopic heart transplant (OHT) recipients to avoid acute rejection episodes (ARE) during the first year after…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Paradox of Advanced Glycation End-Products in Late Cardiac Biopsies of Heart Transplant Recipients by Zakliczynski, M, Nozynski, J, Konecka-Mrowka, D, Lange, D, Zakliczynska, H, Szygula-Jurkiewicz, B, Zembala, M

    Published in Transplantation proceedings (01-10-2011)
    “…Abstract Background A pilot study of orthotopic heart transplant (OHT) recipients showed that advanced glycation end-product (AGE) deposits were related to…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Survival Benefit in Heart Transplant Recipients Who Have Coronary Artery Disease Confirmed Using Angiography and Are Receiving Sirolimus by Zakliczynski, M, Swierad, M, Nozynski, J, Maruszewski, M, Zembala, M

    Published in Transplantation proceedings (2009)
    “…Abstract Introduction The aim of this study was to assess efficacy and safety of sirolimus (SIR) in heart transplant recipients to prevent further development…”
    Get full text
    Journal Article Conference Proceeding
  8. 8

    Procalcitonin Serum Concentration During Pneumocystis Jiroveci Colonization or Pseudomonas Aeruginosa Infection/Colonization in Lung Transplant Recipients by Zeglen, S, Wojarski, J, Wozniak-Grygiel, E, Siola, M, Szewczyk, M, Kucewicz-Czech, E, Nozynski, J, Zembala, M

    Published in Transplantation proceedings (01-10-2009)
    “…Abstract Background Allograft infection after lung transplantation (OLT) has a significant impact on outcomes and represents a diagnostic challenge…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Cytomegalovirus Infection Does Not Accelerate Microvasculopathy Development in Heart Transplant Recipients by Zakliczynski, M, Krynicka-Mazurek, A, Konecka-Mrowka, D, Nozynski, J, Żegleń, S, Przybylski, R, Zembala, M

    Published in Transplantation proceedings (01-10-2009)
    “…Abstract Background Clinical studies with intravascular ultrasound have suggested that even subclinical cytomegalovirus (CMV) infections increase intimal…”
    Get full text
    Journal Article Conference Proceeding
  10. 10
  11. 11

    Different Role of Advanced Glycation End Products in Pathology of Transplanted Heart in Patients With or Without Diabetes Mellitus Type 2 by Zakliczynski, M, Nozynski, J, Konecka-Mrowka, D, Pyka, L, Trybunia, D, Nikiel, B, Mlynarczyk-Liszka, J, Lange, D, Zembala, M

    Published in Transplantation proceedings (01-10-2009)
    “…Abstract Background Aim of the study was to localize advanced glycation end products (AGEs) in late endomyocardial biopsies (EMBs) of orthotopic heart…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Immunohistological diagnosis of myocarditis : Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury by WOJNICZ, R, NOWALANY-KOZIELSKA, E, WODNIECKI, J, SZCZUREK-KATANSKI, K, NOZYNSKI, J, ZEMBALA, M, ROZEK, M. M

    Published in European heart journal (01-10-1998)
    “…The aim of this study was to characterize the up-regulation of major histocompatibility complex antigens class I (HLA-A, B, C) and class II (HLA-DR), and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Mixed Cellular and Humoral Acute Rejection in Elective Biopsies From Heart Transplant Recipients by Zeglen, S, Zakliczynski, M, Wozniak-Grygiel, E, Nozynski, J, Laszewska, A, Wojarski, J, Wojnicz, R, Przybylski, R, Kucewicz-Czech, E, Zembala, M

    Published in Transplantation proceedings (01-10-2009)
    “…Abstract Objective Acute cellular rejection in heart transplants is characterized by an active lymphocytic infiltration, whereas the humoral response shows…”
    Get full text
    Journal Article Conference Proceeding
  15. 15
  16. 16
  17. 17

    Deterioration of renal function after replacement of cyclosporine with sirolimus in five patients with severe renal impairment late after heart transplantation by Zakliczynski, M, Nozynski, J, Zakliczynska, H, Rozentryt, P, Zembala, M

    Published in Transplantation proceedings (01-09-2003)
    “…A retrospective analysis of all cases when cyclosporine (CyA) was replaced with sirolimus (SIR) to avoid the renal toxicity of CyA late after heart transplant…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    What Else Distinguishes Cellular Rejection Grade 1A From 0? Annexin V and BCL in Elective Biopsies Received From Heart Transplant Recipients by Zeglen, S, Nozynski, J, Wozniak-Grygiel, E, Zakliczynski, M, Kucewicz-Czech, E, Laszewska, A, Cichoracka, A, Zembala, M

    Published in Transplantation proceedings (01-10-2009)
    “…Abstract Background Despite morphologic differences of lymphocytes aggregation between nonrejection (0 on the International Society for Heart and Lung…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Transplanted Heart Cardiomyocytes Reveal Continous Expression of Antiapoptotic Bcl-2 Protein by Nozynski, J, Zakliczynski, M, Zembala-Nozynska, E, Konecka-Mrowka, D, Nikiel, B, Przybylski, R, Lange, D, Maruszewski, M, Zembala, M

    Published in Transplantation proceedings (01-11-2007)
    “…Abstract Background Apoptotic mechanisms take place in cardiocyte death during acute heart graft rejection and remodeling by the mitochondrial pathway. This…”
    Get full text
    Journal Article Conference Proceeding
  20. 20

    Thymoglobulin Administered Early After Heart Transplantation Reduces Early Myocardial Hypertrophy Assessed by Morphometric Studies by Nozynski, J, Zakliczynski, M, Zembala-Nozynska, E, Konecka-Mrowka, D, Nikiel, B, Lange, D, Przybylski, R, Zembala, M

    Published in Transplantation proceedings (01-11-2007)
    “…Abstract The aim of this study was to assess the effects of early thymoglobulin administration on cardiocyte nuclear status in orthotopic heart transplant…”
    Get full text
    Journal Article Conference Proceeding